Peptobiotics
PrivateLast Round
Series A
Apr 9, 2024
Total Funding Raised
$6.38M
Company Overview
Peptobiotics operates in Healthcare & Life Sciences and is based in Singapore. Its latest recorded funding round was a Series A round in April 2024.
Peptobiotics is a biotechnology company that develops antimicrobial peptide technology to replace the use of antibiotics in agriculture.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Peptobiotics Comparables
Compare Peptobiotics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Proteon Pharmaceuticals | 79% | |
| NovoBind Livestock Therapeutics Inc. | 76% | |
| Phagos | 71% |
For institutional investors. Book with your work email.
Peptobiotics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 9, 2024 | ||||
| Grant | Oct 27, 2022 | ||||
| Seed | Jan 1, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Peptobiotics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Startup SG | Grant |
| SEEDS Capital | Series A |
| Ponderosa Ventures | Seed |
| Ponderosa Ventures | Series A |
| The Trendlines Group | Seed, Series A |
| The Yield Lab Asia Pacific | Seed, Series A |
| Entrepreneurs First | Seed, Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
Monthly visitors increased 313% MoM.
- May 1, 2025
Monthly visitors grew 146% MoM, from 91 to 224.
For institutional investors. Book with your work email.
Peptobiotics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Peptobiotics's valuation, stock price, and market status.
Is Peptobiotics a public or private company?
Peptobiotics is a private company.
What is the current stock price of Peptobiotics?
Peptobiotics is a private company, so its shares have no public market price. Caplight tracks Peptobiotics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Peptobiotics worth (valuation)?
Valuation information for Peptobiotics is not publicly available.
Can I buy Peptobiotics stock?
Peptobiotics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Peptobiotics's last funding round?
Peptobiotics's most recent funding round was Series A on April 9, 2024.
Who are the main investors in Peptobiotics?
Key investors in Peptobiotics include Hatch Blue.
Will Peptobiotics IPO soon?
No public IPO plans have been announced for Peptobiotics.
How can I track Peptobiotics secondary market activity?
Caplight tracks bids, offers, and trades in Peptobiotics's shares on secondary markets.